Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer's disease.
Srinivasan S, Kancheva D, De Ren S, Saito T, Jans M, Boone F, Vandendriessche C, Paesmans I, Maurin H, Vandenbroucke RE, Hoste E, Voet S, Scheyltjens I, Pavie B, Lippens S, Schwabenland M, Prinz M, Saido T, Bottelbergs A, Movahedi K, Lamkanfi M, van Loo G.
Srinivasan S, et al. Among authors: boone f.
Front Immunol. 2024 Jan 29;15:1323409. doi: 10.3389/fimmu.2024.1323409. eCollection 2024.
Front Immunol. 2024.
PMID: 38352874
Free PMC article.